ERC-SG-LS7
ERC-SG-LS7
Programme: H2020
106 projects · €153,161,413 total EU contribution (project-level) · 97 participating organizations · 17 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€153,161,413
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (14)
- Germany (13)
- Netherlands (11)
- Spain (10)
- Italy (9)
- IL (6)
- CH (5)
- DK (5)
- France (5)
- BE (4)
- SE (4)
- EL (3)
- FI (3)
- EE (1)
- HU (1)
- IE (1)
- PT (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5 projects · UK
- UNIVERSITY COLLEGE LONDON4 projects · —
- AU3 projects · DK
- EPFL3 projects · CH
- FONDAZIONE TELETHON ETS3 projects · IT
- HELSINGIN YLIOPISTO3 projects · FI
- INSERM3 projects · FR
- BGU2 projects · IL
- CEA2 projects · FR
- ETH Zürich2 projects · CH
- HMGU2 projects · DE
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2 projects · UK
Projects
Page 10 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Signals for accommodative responses in humans SACCO · 309416 | FP7 | €1,384,200 | €1,384,200 | Details |
Engineering Vascularized Tissues ENGVASC · 281501 | FP7 | €1,500,000 | €1,500,000 | Details |
Integrating the Multiple Meta-Analysis: a framework for evaluating and ranking multiple health care technologies IMMA · 260559 | FP7 | €592,500 | €592,500 | Details |
Towards the optimization of hydrogen production by nitrogenase TOHPN · 205442 | FP7 | €1,968,000 | €1,968,000 | Details |
Elucidating early pathogenic mechanisms of neurodegeneration in Parkinson's disease through a humanized dynamic in vitro model PD-HUMMODEL · 311736 | FP7 | €1,324,802 | €1,324,802 | Details |
Exploring the aggressiveness of prostate cancer to enable an individualised treatment approach EXACTA · 243115 | FP7 | €1,800,209 | €1,800,209 | Details |
DNA Adduct Molecular Probes: Elucidating the Diet-Cancer Connection at Chemical Resolution DNA-AMP · 260341 | FP7 | €1,500,000 | €1,500,000 | Details |
The economic evaluation of end of life care ECONENDLIFE · 261098 | FP7 | €999,177 | €999,177 | Details |
Child health intervention interactions in low-income countries CHILIC · 243149 | FP7 | €1,686,043 | €1,686,043 | Details |
Towards understanding cerebral small vessel disease: Innovative, MRI-based, functional markers to discover the terra incognita between large vessels and macroscopic brain lesions SMALLVESSELMRI · 337333 | FP7 | €1,499,561 | €1,499,561 | Details |